U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C27H31N2O6S2.Na
Molecular Weight 566.665
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOSULFAN BLUE

SMILES

[Na+].CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(C=C2)=[N+](CC)CC)C3=C(C=CC(=C3)S([O-])(=O)=O)S([O-])(=O)=O

InChI

InChIKey=NLUFDZBOHMOBOE-UHFFFAOYSA-M
InChI=1S/C27H32N2O6S2.Na/c1-5-28(6-2)22-13-9-20(10-14-22)27(21-11-15-23(16-12-21)29(7-3)8-4)25-19-24(36(30,31)32)17-18-26(25)37(33,34)35;/h9-19H,5-8H2,1-4H3,(H-,30,31,32,33,34,35);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C27H31N2O6S2
Molecular Weight 543.675
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Isosulfan Blue is a synthetic visual lymphatic imaging agent. Injected into the periphery of the tumor site, isosulfan blue localizes to the lymphatic system and aids in the surgical identification of tumor sentinel nodes which stain blue. The chemical name of isosulfan blue is N-[4-[[4-(diethylamino)phenyl] (2,5-disulfophenyl) methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium hydroxide, inner salt, sodium salt. Isosulfan blue is a greenish blue color hygroscopic powder. Isosulfan blue injection 1% is a contrast agent for the delineation of lymphatic vessels. Isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
ISOSULFAN BLUE

Approved Use

Lymphatic Vessel Delineation
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
99%
unknown, subcutaneous
ISOSULFAN BLUE plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Other AEs: Hypersensitivity, Respiratory distress...
Other AEs:
Hypersensitivity (2%)
Respiratory distress (grade 4)
Shock (grade 4)
Angioedema (grade 4)
Urticaria (grade 4)
Pruritus (grade 4)
Sources:
AEs

AEs

AESignificanceDosePopulation
Hypersensitivity 2%
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Angioedema grade 4
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Pruritus grade 4
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Respiratory distress grade 4
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Shock grade 4
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Urticaria grade 4
3 mL single, subcutaneous
Studied dose
Dose: 3 mL
Route: subcutaneous
Route: single
Dose: 3 mL
Sources:
unhealthy
Patents

Patents

Sample Use Guides

Isosulfan blue injection 1% is to be administered subcutaneously, one-half (1/2) mL into three interdigital spaces of each extremity per study. A maximum dose of 3 mL isosulfan blue is, therefore, injected.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:27:38 GMT 2025
Edited
by admin
on Mon Mar 31 18:27:38 GMT 2025
Record UNII
39N9K8S2A4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SULPHAN BLUE 2,5-DISULFOPHENYL ISOMER
MI  
Preferred Name English
ISOSULFAN BLUE
ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN  
Official Name English
Isosulfan blue [WHO-DD]
Common Name English
SULPHAN BLUE 2,5-DISULFOPHENYL ISOMER [MI]
Common Name English
(4-(.ALPHA.-(P-(DIETHYLAMINO)PHENYL)-2,5-DISULFOBENZYLIDENE)-2,5-CYCLOHEXADIEN-1-YLIDENE)DIETHYLAMMONIUM HYDROXIDE, INNER SALT, SODIUM SALT
Common Name English
P-1888
Code English
ISO-SULFAN BLUE
Common Name English
ETHANAMINIUM, N-(4-((4-(DIETHYLAMINO)PHENYL)(2,5-DISULFOPHENYL)METHYLENE)-2,5-CYCLOHEXADIEN-1-YLIDENE)-N-ETHYL-, INNER SALT, SODIUM SALT
Common Name English
LYMPHAZURIN
Brand Name English
ISOSULFAN BLUE [ORANGE BOOK]
Common Name English
SODIUM 2-((4-(DIETHYLAMINO)PHENYL)(4-(DIETHYLIMINIO)CYCLOHEXA-2,5-DIEN-1-YLIDENE)METHYL)BENZENE-1,4-DISULPHONATE
Systematic Name English
NSC-734902
Code English
P-4125
Code English
SODIUM 2-((4-(DIETHYLAMINO)PHENYL)(4-(DIETHYLIMINIO)CYCLOHEXA-2,5-DIEN-1-YLIDENE)METHYL)BENZENE-1,4-DISULFONATE
Systematic Name English
ISOSULFAN BLUE [USAN]
Common Name English
ISOSULFAN BLUE [VANDF]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C461
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
Code System Code Type Description
PUBCHEM
50108
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
EVMPD
SUB182640
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
RXCUI
27863
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY RxNorm
FDA UNII
39N9K8S2A4
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
MESH
C025484
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
ChEMBL
CHEMBL1615783
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
HSDB
8071
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
NSC
734902
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
DAILYMED
39N9K8S2A4
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
EPA CompTox
DTXSID8057805
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
CAS
68238-36-8
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
SMS_ID
100000168999
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
DRUG CENTRAL
4503
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
DRUG BANK
DB09136
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
NCI_THESAURUS
C1386
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY
MERCK INDEX
m10387
Created by admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
PRIMARY Merck Index
Related Record Type Details
ACTIVE MOIETY